von Wehren, U., and D. von Torklus. 1983. Arthritis following rubella immunization [in German]. Zeitschrift fur Orthopadie und Ihre Grenzgebiete 121(6):749-750.

Wakefield, A. J., S. H. Murch, A. Anthony, J. Linnell, D. M. Casson, M. Malik, M. Berelowitz, A. P. Dhillon, M. A. Thomson, P. Harvey, A. Valentine, S. E. Davies, and J. A. Walker-Smith. 1998. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351(9103):637-641.

Ward, K. N., N. J. Bryant, N. J. Andrews, J. S. Bowley, A. Ohrling, C. M. Verity, E. M. Ross, and E. Miller. 2007. Risk of serious neurologic disease after immunization of young children in Britain and Ireland. Pediatrics 120(2):314-321.

Watson, J. G. 1990. Letter to the editor. International Journal of Pediatric Otorhinolaryngology 19(2):189-190.

Weibel, R. E., and D. E. Benor. 1996. Chronic arthropathy and musculoskeletal symptoms associated with rubella vaccines: A review of 124 claims submitted to the national vaccine injury compensation program. Arthritis and Rheumatism 39(9):1529-1534.

Weibel, R. E., A. J. Carlson, Jr., and V. M. Villarejos. 1980a. Clinical and laboratory studies of combined live measles, mumps, and rubella vaccines using the RA 27/3 rubella virus. Proceedings of the Society for Experimental Biology and Medicine 165(2):323-326.

Weibel, R. E., V. Caserta, D. E. Benor, and G. Evans. 1998. Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: A review of claims submitted to the national vaccine injury compensation program. Pediatrics 101(3 Pt 1):383-387.

Weibel, R. E., J. Stokes, E. B. Buynak, J. E. Whitman, and M. R. Hilleman. 1967. Live attenuated mumps-virus vaccine: Clinical and serologic aspects in a field evaluation. New England Journal of Medicine 276(5):245-251.

Weibel, R. E., V. M. Villarejos, and E. B. Klein. 1980b. Clinical and laboratory studies of live attenuated RA 27/3 and HPV 77-DE rubella virus vaccines. Proceedings of the Society for Experimental Biology and Medicine 165(1):44-49.

Weller, T. H., and F. A. Neva. 1962. Propagation in tissue culture of cytopathic agents from patients with rubella-like illness. Proceedings of the Society for Experimental Biology and Medicine 111(1):215-225.

Wiersbitzky, S., R. Bruns, and B. Beyer. 1992a. Incubation vaccination (“post-exposure vaccination”) with MMR vaccine during a mumps epidemic? The pediatric vaccine counseling unit [in German]. Kinderarztliche Praxis 60(7):207-208.

Wiersbitzky, S., R. Bruns, and R. Mentel. 1993a. Exanthema with high fever and cerebral seizure susceptibility after mumps-measles-rubella (MMR) preventive vaccination? [in German]. Kinderarztliche Praxis 61(6):227-228.

Wiersbitzky, S., R. Bruns, A. Peters, and R. Mentel. 1992b. Encephalitis, meningitis serosa and parotitis after MMR preventive vaccination? The pediatric vaccination counseling unit [in German]. Kinderarztliche Praxis 60(7):203-205.

Wiersbitzky, S., R. Bruns, and U. Schmidt. 1993b. Cerebral seizures and/or encephalitis after MMR, oral polio, HiB or DPT vaccination? [in German]. Kinderarztliche Praxis 61(6):232-234.

Wiersbitzky, S., C. Burtzlaff, H. Wiersbitzky, and R. Bruns. 1995. Postvaccinal convulsions and epilepsy [in German]. Sozialpadiatrie und Kinderarztliche Praxis 17(9):517-519.

Wiersbitzky, S., C. Schroder, and C. Burtzlaff. 1991. Vaccination encephalopathy after measles vaccination simulating recurrent cardiovascular dysregulation? The pediatric vaccination counseling unit [in German]. Kinderarztliche Praxis 59(6):187-188.

Zheng, D. P., T. K. Frey, J. Icenogle, S. Katow, E. S. Abernathy, K. J. Song, W. B. Xu, V. Yarulin, R. G. Desjatskova, Y. Aboudy, G. Enders, and M. Croxson. 2003. Global distribution of rubella virus genotypes. Emerging Infectious Diseases 9(12):1523-1530.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement